Position in AZN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,287,838,906
New position
Shares Held
6,529,961
first reported quarter
Ownership
0.421%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 73.7368416136023.ToString("F0")%
Shared 0.ToString("F0")%
None 26.263158386397713.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $5,105,423,958 across 13 Drug Manufacturers - General names. AZN ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,690,502 | $1,390,986,307 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
6,529,961 | $1,287,838,906 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,964,890 | $476,936,615 | |
| 4 | LLY |
ELI LILLY & Co
|
504,764 | $464,266,781 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,094,227 | $431,242,416 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,879,864 | $417,263,749 | |
| 7 | ABBV |
AbbVie Inc.
|
1,393,938 | $303,167,574 | |
| 8 | PFE |
Pfizer Inc
|
5,490,142 | $154,163,186 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,287,838,906 | 6,529,961 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||